Biochemical Modulation of Aracytidine (Ara-C) Effects by GTI-2040, a Ribonucleotide Reductase Inhibitor, in K562 Human Leukemia Cells

Por Chen, Ping, Aimiuwu, Josephine, Xie, Zhiliang, Wei, Xiaohui, Liu, Shujun, Klisovic, Rebecca, Marcucci, Guido, Chan, Kenneth K.
Publicado em 2010

DNMT3A Mutations and Response to the Hypomethylating Agent Decitabine in Acute Myeloid Leukemia

Por Metzeler, Klaus H., Walker, Alison, Geyer, Susan, Garzon, Ramiro, Klisovic, Rebecca B., Bloomfield, Clara D., Blum, William, Marcucci, Guido
Publicado em 2011

Characterization of in vitro and in vivo hypomethylating effects of decitabine in acute myeloid leukemia by a rapid, specific and sensitive LC-MS/MS method

Por Liu, Zhongfa, Liu, Shujun, Xie, Zhiliang, Blum, William, Perrotti, Danilo, Paschka, Peter, Klisovic, Rebecca, Byrd, John, Chan, Kenneth K., Marcucci, Guido
Publicado em 2007

RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia

Por Aimiuwu, Josephine, Wang, Hongyan, Chen, Ping, Xie, Zhiliang, Wang, Jiang, Liu, Shujun, Klisovic, Rebecca, Mims, Alice, Blum, William, Marcucci, Guido, Chan, Kenneth K.
Publicado em 2012

Adherence Trajectories in Oral Therapy for Chronic Myeloid Leukemia: Overview of a Research Protocol

Por Yeager, Katherine A., Waldrop-Valverde, Drenna, Paul, Sudeshna, Bruner, Deborah Watkins, Klisovic, Rebecca, Burns, Emily, Mason, Tamara A., Patel, Nisha, Jennings, Bonnie Mowinski
Publicado no Res Nurs Health (2020)

A LC-MS/MS Method for the Analysis of Intracellular Nucleoside Triphosphate Levels

Por Chen, Ping, Liu, Zhongfa, Liu, Shujun, Xie, Zhiliang, Aimiuwu, Josephine, Pang, Jiuxia, Klisovic, Rebecca, Blum, William, Grever, Michael R., Marcucci, Guido, Chan, Kenneth K.
Publicado em 2009

Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species mediated cytotoxicity in canine B-cell lymphoma

Por Mani, Rajeswaran, Yan, Ribai, Mo, Xiaokui, Chen, Ching-Shih, Phelps, Mitch A., Klisovic, Rebecca, Byrd, John C., Kisseberth, William C., London, Cheryl A., Muthusamy, Natarajan
Publicado no Vet Comp Oncol (2016)

Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia

Por Walker, Alison R., Klisovic, Rebecca B., Garzon, Ramiro, Schaaf, Larry J., Humphries, Kristina, Devine, Steven M., Byrd, John C., Grever, Michael R., Marcucci, Guido, Blum, William
Publicado em 2013

Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis Following Allogeneic Peripheral Blood Cell Transplantation

Por Hamadani, Mehdi, Hofmeister, Craig C., Jansak, Buffy, Phillips, Gary, Elder, Patrick, Blum, William, Penza, Sam, Lin, Thomas S., Klisovic, Rebecca, Marcucci, Guido, Farag, Sherif S., Devine, Steven M.
Publicado em 2008

Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia

Por Ranganathan, Parvathi, Yu, Xueyan, Na, Caroline, Santhanam, Ramasamy, Shacham, Sharon, Kauffman, Michael, Walker, Alison, Klisovic, Rebecca, Blum, William, Caligiuri, Michael, Croce, Carlo M., Marcucci, Guido, Garzon, Ramiro
Publicado em 2012

Midostaurin, Bortezomib and MEC in Relapsed/Refractory Acute Myeloid Leukemia

Por Walker, Alison R., Wang, Hongyan, Walsh, Katherine, Bhatnagar, Bhavana, Vasu, Sumithira, Garzon, Ramiro, Canning, Renee, Geyer, Susan, Wu, Yue-Zhong, Devine, Steven M., Klisovic, Rebecca, Blum, William, Marcucci, Guido
Publicado no Leuk Lymphoma (2016)

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma

Por Jaglowski, Samantha M., Ruppert, Amy S., Hofmeister, Craig C., Elder, Patrick, Blum, William, Klisovic, Rebecca, Vasu, Sumithira, Penza, Sam, Efebera, Yvonne A, Benson, Don M., Devine, Steven M., Andritsos, Leslie A
Publicado em 2014

Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia

Por Klisovic, Rebecca B., Blum, William, Liu, Zhongfa, Xie, Zhiliang, Kefauver, Cheryl, Huynh, Lenguyen, Zwiebel, James A., Devine, Steven M., Byrd, John C., Grever, Michael R., Chan, Kenneth K., Marcucci, Guido
Publicado no Leuk Lymphoma (2013)

Lower Dose of Antithymocyte Globulin (ATG) does not increase Graft-vs-Host Disease (GVHD) in Patients Undergoing Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem...

Por Salem, Galena, Ruppert, Amy S., Elder, Patrick, Hofmeister, Craig C., Benson, Don M., Penza, Sam, Andritsos, Leslie, Klisovic, Rebecca, Vasu, Sumithira, Blum, William, Devine, Steven M, Jaglowski, Samantha, Efebera, Yvonne A.
Publicado no Leuk Lymphoma (2014)

Phase I study of AR-42 and decitabine in acute myeloid leukemia

Por Liva, Sophia G., Coss, Christopher C., Wang, Jiang, Blum, William, Klisovic, Rebecca, Bhatnagar, Bhavana, Walsh, Katherine, Geyer, Susan, Zhao, Qiuhong, Garzon, Ramiro, Marcucci, Guido, Phelps, Mitch A., Walker, Alison R.
Publicado no Leuk Lymphoma (2020)

Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia

Por Gopalakrishnan, Bhavani, Cheney, Carolyn, Mani, Rajeswaran, Mo, Xiaokui, Bucci, Donna, Walker, Alison, Klisovic, Rebecca, Bhatnagar, Bhavana, Walsh, Katherine, Rueter, Bjoern, Waizenegger, Irene C., Heider, Karl-Heinz, Blum, William, Vasu, Sumithira, Muthusamy, Natarajan
Publicado no Oncotarget (2018)

Pharmacokinetics and Dose Escalation of the Heat Shock Protein Inhibitor 17-AAG in Combination with Bortezomib in Relapsed or Refractory Acute Myeloid Leukemia

Por Walker, Alison R., Klisovic, Rebecca, Johnston, Jeffrey S., Jiang, Yao, Geyer, Susan, Kefauver, Cheryl, Binkley, Philip, Byrd, John C., Grever, Michael R., Garzon, Ramiro, Phelps, Mitch A., Marcucci, Guido, Blum, Kristie A., Blum, William
Publicado em 2013

Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia

Por Ranganathan, Parvathi, Yu, Xueyan, Santhanam, Ramasamy, Hofstetter, Jessica, Walker, Alison, Walsh, Katherine, Bhatnagar, Bhavana, Klisovic, Rebecca, Vasu, Sumithira, Phelps, Mitch A., Devine, Steven, Shacham, Sharon, Kauffman, Michael, Marcucci, Guido, Blum, William, Garzon, Ramiro
Publicado no Blood (2015)

Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML

Por Jeon, Jae Yoon, Zhao, Qiuhong, Buelow, Daelynn R., Phelps, Mitch, Walker, Alison R., Mims, Alice S., Vasu, Sumithira, Behbehani, Gregory, Blachly, James, Blum, William, Klisovic, Rebecca B., Byrd, John C., Garzon, Ramiro, Baker, Sharyn D., Bhatnagar, Bhavana
Publicado no Invest New Drugs (2019)

Selinexor in Combination with Decitabine in Patients with Acute Myeloid Leukemia: Results from a Phase 1 study

Por Bhatnagar, Bhavana, Zhao, Qiuhong, Mims, Alice S., Vasu, Sumithira, Behbehani, Gregory K., Larkin, Karilyn, Blachly, James S., Blum, William, Klisovic, Rebecca B., Ruppert, Amy S., Orwick, Shelley, Oakes, Christopher, Ranganathan, Parvathi, Byrd, John C., Walker, Alison R., Garzon, Ramiro
Publicado no Leuk Lymphoma (2019)